PTGS2 and ulcerative colitis: It was recently shown that cyclooxygenase-2 (COX-2), the rate-limiting enzyme in the arachidonic acid signaling pathway, was constitutively overexpressed in ulcerative colitis patients who did not respond to TNFα inhibitors [9].